Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 148
- +6 vs. Q2 2025
- Portfolio value
- $4.81B
- +$275.6M (+6.1%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MOHMolina Healthcare, Inc. | COM | 90,985 | $17.4M | 0.4% | +16,963+22.9% | Added | History |
| ALGNAlign Technology Inc | COM | 144,676 | $18.1M | 0.4% | −6,111−4.1% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 326,867 | $18.7M | 0.4% | −5,469−1.6% | Reduced | History |
| HUMHumana Inc | Stock | 76,310 | $19.9M | 0.4% | +27,186+55.3% | Added | History |
| COOCooper Companies, Inc. | COM | 292,265 | $20.0M | 0.4% | −63,809−17.9% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 245,202 | $24.2M | 0.5% | −22,514−8.4% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 65,607 | $28.0M | 0.6% | −33,515−33.8% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 97,506 | $29.0M | 0.6% | −15,827−14.0% | Reduced | History |
| STESTERIS plc | SHS USD | 118,112 | $29.2M | 0.6% | +8,225+7.5% | Added | History |
| MCKMcKesson Corp | Stock | 37,957 | $29.3M | 0.6% | −2,509−6.2% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 4,094,458 | $30.0M | 0.6% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 40,514 | $30.9M | 0.6% | −406−1.0% | Reduced | History |
| DHRDanaher Corp | Stock | 163,876 | $32.5M | 0.7% | +27,065+19.8% | Added | History |
| ELVElevance Health, Inc. | Stock | 104,971 | $33.9M | 0.7% | +22,918+27.9% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 463,063 | $34.8M | 0.7% | −52,405−10.2% | Reduced | History |
| CICigna Group | Stock | 122,486 | $35.3M | 0.7% | +11,774+10.6% | Added | History |
| PENPenumbra Inc | COM | 146,895 | $37.2M | 0.8% | −27,155−15.6% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 170,870 | $39.6M | 0.8% | +11,209+7.0% | Added | History |
| BHVNBiohaven Ltd. | COM | 2,802,853 | $42.1M | 0.9% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 8,345,610 | $43.6M | 0.9% | +114,740+1.4% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,775,997 | $45.0M | 0.9% | 00.0% | Unchanged | History |
| RMDResmed Inc | COM | 164,834 | $45.1M | 0.9% | −968−0.6% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 76,587 | $48.9M | 1.0% | +39+0.1% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 106,185 | $51.5M | 1.1% | −7,359−6.5% | Reduced | History |
| DXCMDexcom Inc | COM | 786,118 | $52.9M | 1.1% | −74,710−8.7% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 296,894 | $55.6M | 1.2% | −19,838−6.3% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 170,057 | $58.7M | 1.2% | +27,761+19.5% | Added | History |
| PODDInsulet Corp | Stock | 212,005 | $65.5M | 1.4% | −7,008−3.2% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 896,633 | $69.7M | 1.4% | +7,556+0.8% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 2,889,288 | $70.1M | 1.5% | 00.0% | Unchanged | History |
| MDTMedtronic plc | Stock | 759,861 | $72.4M | 1.5% | −161,182−17.5% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,557,669 | $92.0M | 1.9% | +250,100+7.6% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 2,152,862 | $93.8M | 1.9% | +2,152,862 | New | – |
| IMCRImmunocore Holdings plc | ADS | 2,796,803 | $101.6M | 2.1% | +354,973+14.5% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 2,389,314 | $113.4M | 2.4% | +404,042+20.4% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 3,244,537 | $120.8M | 2.5% | +297,242+10.1% | Added | History |
| INCYIncyte Corp | COM | 1,440,686 | $122.2M | 2.5% | −129,647−8.3% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 3,714,736 | $149.1M | 3.1% | +124,586+3.5% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 348,626 | $155.9M | 3.2% | −30,102−7.9% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 1,659,849 | $162.1M | 3.4% | −105,345−6.0% | Reduced | History |
| SYKStryker Corp | Stock | 451,096 | $166.8M | 3.5% | −83,993−15.7% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,478,563 | $198.0M | 4.1% | −85,459−5.5% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 505,805 | $198.1M | 4.1% | +64,195+14.5% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 446,524 | $203.6M | 4.2% | −229,843−34.0% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 1,763,105 | $247.5M | 5.1% | −56,895−3.1% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 5,573,838 | $260.3M | 5.4% | +994,538+21.7% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 546,328 | $402.9M | 8.4% | −24,711−4.3% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 6,244,451 | $408.5M | 8.5% | −1,608,747−20.5% | Reduced | History |
Sold out since Q2 2025 (11)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| BPMCBlueprint Medicines Corp | COM | 284,900 | $36.5M | 0.8% | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,733,547 | $6.78M | 0.1% | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 15,927 | $1.51M | <0.1% | History |
| NVONovo Nordisk A S | ADR | 6,500 | $448.6K | <0.1% | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 24,008 | $336.6K | <0.1% | History |
| ADMAAdma Biologics, Inc. | COM | 16,900 | $307.7K | <0.1% | History |
| TVTXTravere Therapeutics, Inc. | COM | 18,303 | $270.9K | <0.1% | History |
| MTSRMetsera, Inc. | COM | 7,800 | $221.9K | <0.1% | History |
| BRBRBellring Brands, Inc. | Stock | 3,500 | $202.8K | <0.1% | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,000 | $197.6K | <0.1% | History |
| OCSOculis Holding AG | ORDINARY SHARES | 9,700 | $188.3K | <0.1% | History |